Biden-Harris Administration Designates Tech Hub in Disputanta, Virginia to Accelerate Growth of the U.S. Pharmaceutical Manufacturing Industry

As part of the President’s Investing in America agenda, the U.S. Department of Commerce identifies regional centers primed for innovation and job creation.

WASHINGTON, DC — The Biden-Harris administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), today announced that the Advanced Pharmaceutical Manufacturing Tech Hub in Disputanta, Virginia, was designated as one of the 31 inaugural Tech Hubs in regions across the country that show potential for rapid growth in key technology sectors.

The Advanced Pharmaceutical Manufacturing Tech Hub, a consortium led by the Commonwealth Center for Advanced Manufacturing, will employ regional assets, scientific capacities, and public and private investment to accelerate the growth, innovation, and sustainability of the U.S.-based pharmaceutical manufacturing industry.

This designation is part of the first phase of the novel Tech Hubs program, authorized by the CHIPS and Science Act, that will invest directly in high-potential U.S. regions and aim to transform them into globally competitive innovation centers. Designation is an endorsement of the region’s strategy to supercharge their respective technological industry to create jobs and strengthen U.S. economic and national security. Designated Tech Hubs are now eligible to apply for the next phase of the Tech Hubs Program that will invest between $50-$75 million in each of 5-10 Designated Hubs.

“President Biden’s Investing in America agenda is rooted in policies that will empower the United States to out-innovate and out-compete the rest of the world. Our Tech Hubs Program is fundamental to that mission and will supercharge innovation across the nation by spurring cutting-edge technological investments and creating 21st century job opportunities in people’s backyards,” said U.S. Secretary of Commerce Gina Raimondo. “Each of these consortia will help us ensure the industries of the future—and their good-paying jobs—start, grow, and remain in the United States.”

“These outstanding consortia exemplify place-based economic development strategies at their best: combining federal resources with regional assets, expertise, and coalitions to implement transformational opportunities,” said Assistant Secretary of Commerce for Economic Development Alejandra Y. Castillo. “As each region develops its own strategy to catalyze innovation and job creation, the entire nation grows more secure and more competitive.”

“The CHIPS and Science Act continues to deliver significant wins for Virginia, supporting the creation of an Advanced Pharmaceutical Manufacturing Tech Hub in the Richmond-Petersburg region. I was proud to support this project, which will help make the Richmond-Petersburg region a critical hub for the manufacturing of advanced pharmaceuticals. Today’s announcement will help boost the American pharmaceutical industry while creating 21st century jobs for Virginians,” said Virginia Senator Mark R. Warner.

“Manufacturing critical medicines, including insulin, in America is good for patients, our workers, our economy, and the stability of our supply chains. That’s why I’ve worked for decades to boost our biotechnology sector in the Richmond region. I helped form and grow the Virginia Biotechnology Research Partnership Authority, a leader of this project, while I was on Richmond City Council, served on the Authority’s board while I was Richmond’s mayor, and appointed its board members while I was governor. Now as Senator, I worked to secure funding from the American Rescue Plan for the project and pushed to make this competitive Tech Hub designation possible. I’ll keep working to advance this critical economic development project for Central Virginia,” said Virginia Senator Tim Kaine.

“Congratulations to the Advanced Pharmaceutical Manufacturing Consortia on its new designation through the Economic Development Administration as a Tech Hub,” said Representative Jennifer McClellan (VA-04). “This recognition is a testament to the commitment and dedication of the consortium members and the incredible innovation taking place in the Fourth District of Virginia. I was proud to advocate for additional federal funding for CCAM and APM from the Department of Commerce, and I am confident this new designation will further strengthen this cluster and position it as a global hub for pharmaceutical manufacturing.”

The 31 Tech Hubs were selected from 198 applications from regional consortia that include industry, academia, state and local governments, economic development organizations, and labor and workforce partners. The Tech Hubs span regions across 32 states and Puerto Rico and represent a cross section of urban and rural regions.

For a full list of Tech Hubs, visit

About the U.S. Economic Development Administration (
The mission of the U.S. Economic Development Administration (EDA) is to lead the federal economic development agenda by promoting competitiveness and preparing the nation’s regions for growth and success in the worldwide economy. An agency within the U.S. Department of Commerce, EDA invests in communities and supports regional collaboration in order to create jobs for U.S. workers, promote American innovation, and accelerate long-term sustainable economic growth.


  • Tech Hubs